.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Covington
Queensland Health
Colorcon
Argus Health
Citi
Boehringer Ingelheim
Moodys
Baxter

Generated: July 28, 2017

DrugPatentWatch Database Preview

SOMA Drug Profile

« Back to Dashboard

What is the patent landscape for Soma, and what generic Soma alternatives are available?

Soma is a drug marketed by Mylan Speciality Lp, Meda Pharms, Ipsen Pharma, and Pharmacia And Upjohn. and is included in five NDAs. There are two patents protecting this drug.

The generic ingredient in SOMA is pegvisomant. One supplier is listed for this compound. Additional details are available on the pegvisomant profile page.

Summary for Tradename: SOMA

Patents:0
Applicants:4
NDAs:5
Suppliers / Packagers: see list4
Bulk Api Vendors: see list54
Clinical Trials: see list7
Patent Applications: see list3,469
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SOMA at DailyMed

Pharmacology for Tradename: SOMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp
SOMA
carisoprodol
CAPSULE;ORAL011792-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
SOMAVERT
pegvisomant
INJECTABLE;SUBCUTANEOUS021106-004Jul 31, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Ipsen Pharma
SOMATULINE DEPOT
lanreotide acetate
SOLUTION;SUBCUTANEOUS022074-001Aug 30, 2007RXYesYes► Subscribe► Subscribe► Subscribe
Meda Pharms
SOMA COMPOUND
aspirin; carisoprodol
TABLET;ORAL012365-005Jul 11, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Ipsen Pharma
SOMATULINE DEPOT
lanreotide acetate
SOLUTION;SUBCUTANEOUS022074-003Aug 30, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
US Army
Chubb
AstraZeneca
Cerilliant
Merck
Boehringer Ingelheim
Queensland Health
QuintilesIMS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot